Zinc in PDB 7xso: Structure of the Type III-E Crispr-Cas Effector Gramp

The binding sites of Zinc atom in the Structure of the Type III-E Crispr-Cas Effector Gramp (pdb code 7xso). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the Structure of the Type III-E Crispr-Cas Effector Gramp, PDB code: 7xso:
Jump to Zinc binding site number: 1; 2; 3; 4;

Zinc binding site 1 out of 4 in the Structure of the Type III-E Crispr-Cas Effector Gramp


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Structure of the Type III-E Crispr-Cas Effector Gramp within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn1801 b:80.5 occ:1.00 SG A:CYS127 2.4 55.8 1.0 SG A:CYS88 2.4 56.8 1.0 SG A:CYS130 2.4 54.2 1.0 SG A:CYS121 2.5 61.9 1.0 CB A:CYS127 3.2 55.8 1.0 CB A:CYS88 3.5 56.8 1.0 CB A:CYS130 3.6 54.2 1.0 CB A:CYS121 3.7 61.9 1.0 N A:CYS88 4.0 56.8 1.0 N A:CYS127 4.2 55.8 1.0 N A:CYS130 4.2 54.2 1.0 CA A:CYS88 4.2 56.8 1.0 CA A:CYS127 4.3 55.8 1.0 CA A:CYS130 4.5 54.2 1.0 C A:CYS88 4.7 56.8 1.0 O A:CYS88 4.8 56.8 1.0 NH1 A:ARG135 4.8 51.8 1.0 C A:CYS127 4.9 55.8 1.0

Zinc binding site 2 out of 4 in the Structure of the Type III-E Crispr-Cas Effector Gramp


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Structure of the Type III-E Crispr-Cas Effector Gramp within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn1802 b:86.1 occ:1.00 SG A:CYS491 2.4 54.9 1.0 SG A:CYS506 2.4 50.9 1.0 SG A:CYS503 2.5 54.5 1.0 SG A:CYS501 2.5 55.0 1.0 CB A:CYS506 3.3 50.9 1.0 CB A:CYS503 3.3 54.5 1.0 CB A:CYS491 3.5 54.9 1.0 CB A:CYS501 3.6 55.0 1.0 N A:CYS506 4.2 50.9 1.0 N A:CYS491 4.2 54.9 1.0 CA A:CYS506 4.3 50.9 1.0 N A:CYS503 4.3 54.5 1.0 CA A:CYS503 4.4 54.5 1.0 CA A:CYS491 4.4 54.9 1.0 O A:CYS491 4.8 54.9 1.0 C A:CYS491 4.9 54.9 1.0 C A:CYS503 4.9 54.5 1.0 CA A:CYS501 4.9 55.0 1.0 O A:CYS503 5.0 54.5 1.0

Zinc binding site 3 out of 4 in the Structure of the Type III-E Crispr-Cas Effector Gramp


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 3 of Structure of the Type III-E Crispr-Cas Effector Gramp within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn1803 b:81.4 occ:1.00 ND1 A:HIS747 2.1 67.5 1.0 CE1 A:HIS747 2.4 67.5 1.0 SG A:CYS752 2.4 60.5 1.0 SG A:CYS750 2.4 67.6 1.0 SG A:CYS755 2.5 54.7 1.0 CB A:CYS750 3.2 67.6 1.0 CB A:CYS755 3.4 54.7 1.0 CB A:CYS752 3.4 60.5 1.0 CG A:HIS747 3.5 67.5 1.0 NE2 A:HIS747 3.7 67.5 1.0 N A:CYS752 4.0 60.5 1.0 CD2 A:HIS747 4.2 67.5 1.0 CA A:CYS752 4.3 60.5 1.0 CB A:HIS747 4.3 67.5 1.0 N A:CYS755 4.4 54.7 1.0 CA A:CYS755 4.5 54.7 1.0 CA A:CYS750 4.6 67.6 1.0 CA A:HIS747 4.6 67.5 1.0 N A:THR751 4.7 64.5 1.0 NZ A:LYS744 4.8 65.8 1.0 O A:HIS747 4.8 67.5 1.0 C A:CYS750 4.8 67.6 1.0 CD A:LYS744 4.9 65.8 1.0 C A:CYS752 4.9 60.5 1.0 CG A:MET754 5.0 54.4 1.0

Zinc binding site 4 out of 4 in the Structure of the Type III-E Crispr-Cas Effector Gramp


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 4 of Structure of the Type III-E Crispr-Cas Effector Gramp within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn1804 b:65.6 occ:1.00 SG A:CYS1406 2.4 50.9 1.0 SG A:CYS1018 2.4 44.9 1.0 SG A:CYS1414 2.4 45.7 1.0 SG A:CYS1417 2.5 43.0 1.0 CB A:CYS1414 2.8 45.7 1.0 CB A:CYS1417 3.2 43.0 1.0 N A:CYS1414 3.6 45.7 1.0 CB A:CYS1018 3.7 44.9 1.0 CB A:CYS1406 3.7 50.9 1.0 CA A:CYS1414 3.8 45.7 1.0 N A:CYS1417 4.1 43.0 1.0 NH1 A:ARG935 4.2 47.8 1.0 CA A:CYS1417 4.3 43.0 1.0 N A:CYS1406 4.4 50.9 1.0 N A:CYS1018 4.5 44.9 1.0 C A:CYS1414 4.5 45.7 1.0 O A:CYS1414 4.6 45.7 1.0 CA A:CYS1406 4.7 50.9 1.0 CA A:CYS1018 4.7 44.9 1.0 C A:LEU1413 4.9 45.5 1.0

X.Liu, L.Zhang, H.Wang, Y.Xiu, L.Huang, Z.Gao, N.Li, F.Li, W.Xiong, T.Gao, Y.Zhang, M.Yang, Y.Feng. Target Rna Activates the Protease Activity of Craspase to Confer Antiviral Defense. Mol.Cell V. 82 4503 2022.
ISSN: ISSN 1097-2765
PubMed: 36306795
DOI: 10.1016/J.MOLCEL.2022.10.007